Cargando…

Elucidation of Inverse Agonist Activity of Bilastine

H(1)-antihistamines antagonize histamine and prevent it from binding to the histamine H(1) receptor (H1R). Some of them also act as inverse agonists, which are more potent than pure antagonists because they suppress the constitutive H1R activity. Bilastine is a non-sedative antihistamine which is on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizuguchi, Hiroyuki, Wakugawa, Tomoharu, Sadakata, Hisato, Kamimura, Seiichiro, Takemoto, Mai, Nakagawa, Tomomi, Yabumoto, Masami, Kitamura, Yoshiaki, Takeda, Noriaki, Fukui, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355758/ https://www.ncbi.nlm.nih.gov/pubmed/32521742 http://dx.doi.org/10.3390/pharmaceutics12060525

Ejemplares similares

Effects of narrow‐band UVB on nasal symptom and upregulation of histamine H(1) receptor mRNA in allergic rhinitis model rats
por: Kamimura, Seiichiro, et al.
Publicado: (2021)

Signaling Pathway of Histamine H(1) Receptor-Mediated Histamine H(1) Receptor Gene Upregulation Induced by Histamine in U-373 MG Cells
por: Mizuguchi, Hiroyuki, et al.
Publicado: (2021)

Betuletol, a Propolis Component, Suppresses IL-33 Gene Expression and Effective against Eosinophilia
por: Shaha, Aurpita, et al.
Publicado: (2022)

Efficacy of dual sublingual immunotherapy with Japanese cedar pollen and house dust mite allergens in patients with allergic rhinitis sensitized to multiple allergens
por: Fujii, Tatsuya, et al.
Publicado: (2022)

Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022)

Experience with bilastine in the management of urticaria: Original Real-world cases of Bilastine In Treatment (ORBIT) in Asia
por: Cheong, Wai Kwong, et al.
Publicado: (2022)

Bilastine: new insight into antihistamine treatment
por: Ridolo, Erminia, et al.
Publicado: (2015)

PMA-induced dissociation of Ku86 from the promoter causes transcriptional up-regulation of histamine H(1) receptor
por: Mizuguchi, Hiroyuki, et al.
Publicado: (2012)

Maackiain is a novel antiallergic compound that suppresses transcriptional upregulation of the histamine H(1) receptor and interleukin-4 genes
por: Mizuguchi, Hiroyuki, et al.
Publicado: (2015)

Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria
por: Sadaba, Belen, et al.
Publicado: (2013)

The safety and tolerability profile of bilastine for chronic urticaria in children
por: Papadopoulos, Nikolaos G., et al.
Publicado: (2019)

Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria
por: Staevska, Maria T
Publicado: (2016)

Effect of Bilastine on Diabetic Nephropathy in DBA2/J Mice
por: Verta, Roberta, et al.
Publicado: (2019)

Up-dosing with bilastine results in improved effectiveness in cold contact urticaria
por: Krause, K, et al.
Publicado: (2013)

Green quality by design HPLC approach for the simultaneous determination of Bilastine and Montelukast
por: Roshdy, Aya, et al.
Publicado: (2023)

Evaluation of the Single-dose Pharmacokinetics of Bilastine in Subjects with Various Degrees of Renal Insufficiency
por: Lasseter, Kenneth C., et al.
Publicado: (2013)

Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement
por: Mösges, Ralph, et al.
Publicado: (2016)

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
por: Wang, Xue Yan, et al.
Publicado: (2016)

Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation
por: Ochoa, Dolores, et al.
Publicado: (2021)

Effectiveness of bilastine and fexofenadine among allergic Rhinitis patients in Ranchi, Jharkhand, India
por: Kumari, Abha, et al.
Publicado: (2022)

Application of a dual mechanistic approach to support bilastine dose selection for older adults
por: Kim, Chaejin, et al.
Publicado: (2021)

Efficacy and Safety of Bilastine in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis
por: Singh Randhawa, Aranjit, et al.
Publicado: (2022)

An Inverse Approach for Elucidating Dendritic Function
por: Torben-Nielsen, Benjamin, et al.
Publicado: (2010)

Bilastine: A New Nonsedating Oral H1 Antihistamine for Treatment of Allergic Rhinoconjunctivitis and Urticaria
por: Wolthers, Ole D.
Publicado: (2013)

Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria
por: Rodríguez, Mónica, et al.
Publicado: (2020)

Bilastine 10 and 20 mg in paediatric and adult patients: an updated practical approach to treatment decisions
por: Leceta, Amalia, et al.
Publicado: (2021)

Lack of Clinical Relevance of Bilastine-Food Interaction in Healthy Volunteers: A Wheal and Flare Study
por: Coimbra, Jimena, et al.
Publicado: (2022)

Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study
por: Kuna, Piotr, et al.
Publicado: (2023)

Elucidation of an Allosteric Mode of Action for a Thienopyrazole RORγt Inverse Agonist
por: de Vries, Rens M. J. M., et al.
Publicado: (2020)

Concomitant bilastine and montelukast as additive therapy for seasonal allergic rhinoconjunctivits and mild‐to‐moderate asthma. The SKY study
por: Lavorini, Federico, et al.
Publicado: (2019)

Pharmacokinetics, Pharmacodynamics and Population Pharmacokinetic/Pharmacodynamic Modelling of Bilastine, a Second-Generation Antihistamine, in Healthy Japanese Subjects
por: Togawa, Michinori, et al.
Publicado: (2016)

Platelet polyphosphate and energy metabolism in professional male athletes (soccer players): A cross‐sectional pilot study
por: Ushiki, Takashi, et al.
Publicado: (2022)

Bilastine vs. hydroxyzine: occupation of brain histamine H(1)-receptors evaluated by positron emission tomography in healthy volunteers
por: Farré, Magí, et al.
Publicado: (2014)

Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department
por: Leceta, Amalia, et al.
Publicado: (2017)

A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria
por: Shah, Bela, et al.
Publicado: (2022)

A Systematic Survey and Characterization of Enhancers that Regulate Sox3 in Neuro-Sensory Development in Comparison with Sox2 Enhancers
por: Nishimura, Naoko, et al.
Publicado: (2012)

One‐year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases
por: Yagami, Akiko, et al.
Publicado: (2016)

Real-Life Experience of Efficacy and Safety of Bilastine in the Refractory Cases of Chronic Spontaneous Urticaria and its Effect on the Quality of Life of Patients
por: De, Abhishek, et al.
Publicado: (2021)

Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study
por: Sinha, Vishakha V., et al.
Publicado: (2023)

Optimized Protocol for Preservation of Human Platelet Samples for Fluorometric Polyphosphate Quantification
por: Kawase, Tomoyuki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_23tugb9unf0o7v9a0ucg1bh531